19-4362694-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_003025.4(SH3GL1):āc.771C>Gā(p.Pro257Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.295 in 1,613,810 control chromosomes in the GnomAD database, including 73,994 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.32 ( 8248 hom., cov: 34)
Exomes š: 0.29 ( 65746 hom. )
Consequence
SH3GL1
NM_003025.4 synonymous
NM_003025.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.285
Genes affected
SH3GL1 (HGNC:10830): (SH3 domain containing GRB2 like 1, endophilin A2) This gene encodes a member of the endophilin family of Src homology 3 domain-containing proteins. The encoded protein is involved in endocytosis and may also play a role in the cell cycle. Overexpression of this gene may play a role in leukemogenesis, and the encoded protein has been implicated in acute myeloid leukemia as a fusion partner of the myeloid-lymphoid leukemia protein. Pseudogenes of this gene are located on the long arm of chromosomes 11 and 17. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 19-4362694-G-C is Benign according to our data. Variant chr19-4362694-G-C is described in ClinVar as [Benign]. Clinvar id is 1238058.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.285 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.572 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH3GL1 | NM_003025.4 | c.771C>G | p.Pro257Pro | synonymous_variant | 8/10 | ENST00000269886.7 | NP_003016.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH3GL1 | ENST00000269886.7 | c.771C>G | p.Pro257Pro | synonymous_variant | 8/10 | 1 | NM_003025.4 | ENSP00000269886.2 | ||
SH3GL1 | ENST00000417295.6 | c.627C>G | p.Pro209Pro | synonymous_variant | 7/9 | 2 | ENSP00000404568.2 | |||
SH3GL1 | ENST00000598564.5 | c.579C>G | p.Pro193Pro | synonymous_variant | 8/10 | 2 | ENSP00000470792.1 |
Frequencies
GnomAD3 genomes AF: 0.320 AC: 48683AN: 152116Hom.: 8240 Cov.: 34
GnomAD3 genomes
AF:
AC:
48683
AN:
152116
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.339 AC: 85075AN: 251202Hom.: 15638 AF XY: 0.331 AC XY: 45015AN XY: 135796
GnomAD3 exomes
AF:
AC:
85075
AN:
251202
Hom.:
AF XY:
AC XY:
45015
AN XY:
135796
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.292 AC: 427156AN: 1461576Hom.: 65746 Cov.: 50 AF XY: 0.292 AC XY: 212481AN XY: 727096
GnomAD4 exome
AF:
AC:
427156
AN:
1461576
Hom.:
Cov.:
50
AF XY:
AC XY:
212481
AN XY:
727096
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.320 AC: 48714AN: 152234Hom.: 8248 Cov.: 34 AF XY: 0.325 AC XY: 24177AN XY: 74422
GnomAD4 genome
AF:
AC:
48714
AN:
152234
Hom.:
Cov.:
34
AF XY:
AC XY:
24177
AN XY:
74422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1485
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Acute myeloid leukemia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at